NFE2L2 and cancer: Moreover, cancer cells can trigger PERK activation as an adaptive mechanism, which in turn stabilizes the nuclear factor erythroid 2-related factor 2 (NRF2) to mitigate oxidative damage by inducing glutathione synthesis [123].